Publication | Open Access
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer
11
Citations
23
References
2020
Year
MODIFY I (NCT01241552), MODIFY II (NCT01513239).
| Year | Citations | |
|---|---|---|
Page 1
Page 1